Insight on Multidrug Resistance and Nanomedicine Approaches to Overcome MDR

Area of Science:

• Oncology
• Pharmacology
• Biochemistry

Background:

• Multidrug resistance (MDR) significantly limits chemotherapy efficacy in cancer patients.
• Key factors contributing to MDR include P-glycoprotein (P-gp) overexpression, cancer stem cells (CSCs), and altered cellular pathways.
• ABC transporters-mediated drug efflux is a primary mechanism of MDR.

Purpose of the Study:

• To review fundamental strategies and recent advancements in overcoming MDR.
• To focus on improving nanomedicine approaches to reverse MDR.
• To explore the mechanics of ABC transporter-associated drug resistance.

Main Methods:

• Literature review of studies on ABC transporters, MDR mechanisms, and therapeutic strategies.
• Analysis of P-gp modulators, siRNAs, antibodies, peptides, and nanomedicine approaches.
• Examination of research on drug binding sites and structures of ABC transporters.

Main Results:

• Drug efflux by ABC transporters is a well-established MDR mechanism.
• Various strategies like P-gp modulators and nanomedicine show promise in combating MDR.
• Nanoparticle and combination nanomedicine strategies offer exciting results for MDR reversal.

Conclusions:

• Understanding ABC transporter mechanics is crucial for developing effective MDR reversal strategies.
• Nanomedicine holds significant potential for overcoming MDR in cancer therapy.
• Continued research into novel strategies is essential to improve patient outcomes.